共 50 条
- [1] Serum levels of osteoprotegerin and receptor activator of nuclear factor-κB ligand as markers of periprosthetic osteolysis JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2006, 88A (07): : 1501 - 1509
- [4] Receptor Activator of Nuclear Factor-κB Ligand (RANKL) Expression in Hepatocellular Carcinoma With Bone Metastasis Annals of Surgical Oncology, 2007, 14 : 1191 - 1199
- [6] The Effect of Osteoprotegerin (OPG)/Receptor Activator of Nuclear Factor-κB Ligand (RANKL)/Receptor Activator of Nuclear Factor-κB (RANK) on Aortic Valve Calcified ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2024, 54 (05): : 633 - 642
- [8] Osteoprotegerin and receptor activator of nuclear factor-κB ligand (RANKL) in the serum of healthy adults INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2002, 17 (03): : 177 - 181
- [10] Receptor activator of nuclear factor κB ligand (RANKL)/osteoprotegerin (OPG) ratio is increased in severe osteolysis AMERICAN JOURNAL OF PATHOLOGY, 2003, 163 (05): : 2021 - 2031